TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomes

PURPOSE: Graft-versus-host disease (GVHD) causes most non-relapse mortality (NRM) following alternative donor (unrelated and mismatched related) hematopoietic cell transplant (HCT). We previously showed that increases in day +7 TNF-receptor-1 (TNFR1) ratios (post-transplant day +7/pre-transplant bas...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Choi, Sung W., Stiff, Patrick, Cooke, Kenneth, Ferrara, James L.M., Braun, Thomas, Kitko, Carrie, Reddy, Pavan, Yanik, Gregory, Mineishi, Shin, Paczesny, Sophie, Hanauer, David, Pawarode, Attaphol, Peres, Edward, Rodriguez, Tulio, Smith, Scott, Levine, John E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3443302/
https://ncbi.nlm.nih.gov/pubmed/22469883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.03.013
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky